Yoshiya Tanaka1, Claire Barrett2, Yuji Hirano3, Kei Ikeda4, Kathy Paizis5, Azusa Sameshima6, Irina Mountian7, Priscilla C Wong8. 1. University of Occupational and Environmental Health, Japan, Kitakyushu, Japan. tanaka@med.uoeh-u.ac.jp. 2. Redcliffe Hospital, Redcliffe and University of Queensland, St Lucia, Australia. 3. Toyohashi Municipal Hospital, Toyohashi, Japan. 4. Chiba University Hospital, Chiba, Japan. 5. Austin Health, and Mercy Hospital for Women, Heidelberg, and Western Health, St Albans, Australia. 6. University of Toyama, Toyama, Japan. 7. UCB Pharma, Brussels, Belgium. 8. The Chinese University of Hong Kong, Hong Kong, HK, Hong Kong.
Abstract
OBJECTIVE: Perspectives of women aged 18-45 years with chronic rheumatic diseases (CRD), and clinicians, in the Asia-Pacific (APAC) region are reported. METHODS: Online surveys were completed by women, pregnant in the past 2-5 years, with moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis (axSpA), and rheumatologists, obstetricians, orthopaedic surgeons who medically manage CRDs. RESULTS: Among 210 (RA 122, PsA 48, axSpA 40) patients, 52% (n = 109/210) delayed their decision to have children, most commonly due to concerns of passing on disease to offspring. 33% (n = 70/210) discussed family planning with a healthcare professional at diagnosis. Patients most often initiated discussions. 94% (n = 193/205) stopped treatment around pregnancy due to fear of fetal harm. 66% (n = 139/210) of patients felt they did not receive all relevant information on the impact of CRDs and treatment on pregnancy. Among 335 clinicians who participated, 82% (n = 143/174) of rheumatologists, 86% (n = 72/84) of obstetricians and 43% (n = 33/77) of orthopaedic surgeons agreed good disease control during pregnancy was their primary goal. 69% (n = 120/174) of rheumatologists were 'very comfortable' with prescribing tumour necrosis factor inhibitors (TNFi) for women aged 18-45 years. Comfort levels generally decreased with the onset of family planning. More obstetricians and orthopaedic surgeons supported avoiding TNFi during pregnancy than rheumatologists (40% [n = 34/84]/38% [n = 29/77] versus 16% [n = 28/174]). Access to more TNFi safety data during pregnancy was considered paramount for increasing clinician comfort. CONCLUSIONS: Patients and physicians need current information and multidisciplinary discussions for improved management of CRD in women in APAC.
OBJECTIVE: Perspectives of women aged 18-45 years with chronic rheumatic diseases (CRD), and clinicians, in the Asia-Pacific (APAC) region are reported. METHODS: Online surveys were completed by women, pregnant in the past 2-5 years, with moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis (axSpA), and rheumatologists, obstetricians, orthopaedic surgeons who medically manage CRDs. RESULTS: Among 210 (RA 122, PsA 48, axSpA 40) patients, 52% (n = 109/210) delayed their decision to have children, most commonly due to concerns of passing on disease to offspring. 33% (n = 70/210) discussed family planning with a healthcare professional at diagnosis. Patients most often initiated discussions. 94% (n = 193/205) stopped treatment around pregnancy due to fear of fetal harm. 66% (n = 139/210) of patients felt they did not receive all relevant information on the impact of CRDs and treatment on pregnancy. Among 335 clinicians who participated, 82% (n = 143/174) of rheumatologists, 86% (n = 72/84) of obstetricians and 43% (n = 33/77) of orthopaedic surgeons agreed good disease control during pregnancy was their primary goal. 69% (n = 120/174) of rheumatologists were 'very comfortable' with prescribing tumour necrosis factor inhibitors (TNFi) for women aged 18-45 years. Comfort levels generally decreased with the onset of family planning. More obstetricians and orthopaedic surgeons supported avoiding TNFi during pregnancy than rheumatologists (40% [n = 34/84]/38% [n = 29/77] versus 16% [n = 28/174]). Access to more TNFi safety data during pregnancy was considered paramount for increasing clinician comfort. CONCLUSIONS: Patients and physicians need current information and multidisciplinary discussions for improved management of CRD in women in APAC.
Authors: Mark Berman; Devy Zisman; Jonathan Wollman; David Levartovsky; Eli Rimon; Ori Elkayam; Daphna Paran Journal: J Rheumatol Date: 2018-09-15 Impact factor: 4.666
Authors: Lisa R Sammaritano; Bonnie L Bermas; Eliza E Chakravarty; Christina Chambers; Megan E B Clowse; Michael D Lockshin; Wendy Marder; Gordon Guyatt; D Ware Branch; Jill Buyon; Lisa Christopher-Stine; Rachelle Crow-Hercher; John Cush; Maurice Druzin; Arthur Kavanaugh; Carl A Laskin; Lauren Plante; Jane Salmon; Julia Simard; Emily C Somers; Virginia Steen; Sara K Tedeschi; Evelyne Vinet; C Whitney White; Jinoos Yazdany; Medha Barbhaiya; Brittany Bettendorf; Amanda Eudy; Arundathi Jayatilleke; Amit Aakash Shah; Nancy Sullivan; Laura L Tarter; Mehret Birru Talabi; Marat Turgunbaev; Amy Turner; Kristen E D'Anci Journal: Arthritis Rheumatol Date: 2020-02-23 Impact factor: 10.995
Authors: Yaël A de Man; Johanna M W Hazes; Hugo van der Heide; Sten P Willemsen; Christianne J M de Groot; Eric A P Steegers; Radboud J E M Dolhain Journal: Arthritis Rheum Date: 2009-11
Authors: Josef S Smolen; Robert B M Landewé; Johannes W J Bijlsma; Gerd R Burmester; Maxime Dougados; Andreas Kerschbaumer; Iain B McInnes; Alexandre Sepriano; Ronald F van Vollenhoven; Maarten de Wit; Daniel Aletaha; Martin Aringer; John Askling; Alejandro Balsa; Maarten Boers; Alfons A den Broeder; Maya H Buch; Frank Buttgereit; Roberto Caporali; Mario Humberto Cardiel; Diederik De Cock; Catalin Codreanu; Maurizio Cutolo; Christopher John Edwards; Yvonne van Eijk-Hustings; Paul Emery; Axel Finckh; Laure Gossec; Jacques-Eric Gottenberg; Merete Lund Hetland; Tom W J Huizinga; Marios Koloumas; Zhanguo Li; Xavier Mariette; Ulf Müller-Ladner; Eduardo F Mysler; Jose A P da Silva; Gyula Poór; Janet E Pope; Andrea Rubbert-Roth; Adeline Ruyssen-Witrand; Kenneth G Saag; Anja Strangfeld; Tsutomu Takeuchi; Marieke Voshaar; René Westhovens; Désirée van der Heijde Journal: Ann Rheum Dis Date: 2020-01-22 Impact factor: 19.103
Authors: Eliza Chakravarty; Megan E B Clowse; Daphnee S Pushparajah; Sarah Mertens; Caroline Gordon Journal: BMJ Open Date: 2014-02-05 Impact factor: 2.692
Authors: Stephanie van den Brandt; Astrid Zbinden; Dominique Baeten; Peter M Villiger; Monika Østensen; Frauke Förger Journal: Arthritis Res Ther Date: 2017-03-20 Impact factor: 5.156